Tuesday 7 April 2015

Phase 1 Clinical Trial of Potential Ebola Vaccine Passes Safety Test, Shows Good Immune Response

The Ebola epidemic has ravaged West Africa for more than a year now. Researchers are working on finding an effective vaccine against the deadly Ebola virus. A new study claimed that an experimental Ebola vaccine called VSV-EBOV appears safe and generates immune response in a small phase 1 clinical trial. Scientists at the Public Health Agency of Canada's National Microbiology Laboratory originally developed the VSV-EBOV vaccine. The vaccine does not contain Ebola ...

via Medindia Health News More READ

No comments:

Post a Comment